News
NEUVOGEN Announces Poster Presentation at the American Association of Cancer Research Annual Meeting
NEUVOGEN, Inc. ("NEUVOGEN THERAPEUTICS" or "NEUVOGEN"), a San Diego based biotechnology company, will present data that its next generation whole tumor cell vaccine (NGEN-143) activates T cells that ...
HONG KONG, China I April 18, 2025 I Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that ebdarokimab, an investigational monoclonal ...
Deciphering the gut biome's, including helminths', influence on human trained immunity will unlock novel immunotherapies harnessing the immune reprogramming potential of their secreted factors and ...
7d
News-Medical.Net on MSNVitamin D curbs colorectal cancer by boosting immunity and blocking tumor growthReview highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...
The human body usually has a strong defense against viral infections, primarily through the rapid production of anti-viral T cells. Specifically, when a virus is detected, T Helper 1 (Th1 ...
Vitamin D exerts immunoregulatory effects by suppressing pro-inflammatory T-helper cells, particularly T-helper 1 (Th1) and Th17 lymphocytes, which play a crucial role in CRC development.
Intraocular inflammation was evaluated by histopathological scoring. Frequencies of Th1/Th17 cells were measured by flow cytometry. Concentrations of IFN-γ/IL-17A, neutrophil elastase (NE) and ...
In SLE, there is an imbalance in Th1/Th2 and Th17/Treg[1,2], activation of B cells in CD4+T cell subsets[3], and abnormal activation of CD4+T cells, as well as skin tissue infiltration and Th2/Th17 ...
and is considered a Th1-mediated disease, supported by the over-expression of interferon-gamma (IFN-γ) in the intestinal lamina propria. IFN-γ has a pleiotropic effect on the intestinal epithelial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results